21
Nov
2011
10
Nov
2011
10
Nov
2011
08
Nov
2011
06
Oct
2011
25
Aug
2011
25
Jul
2011
Posted in I - Series E, Q - 2Q11, R - WEST, X - Device (Cardiology), X - Device (Diagnostic), XX - CA
CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $60M Series E financing. Participants include Longitude Capital, J.P. Morgan, Acadia Woods Partners, Artian Ventures and Briht Capital.
20
Jul
2011
Posted in I - Series D, Q - 2Q11, R - INTERNATIONAL, X - Device (Diagnostic), X - Device (Sequencing)
Oxford Nanopore Technologies (United Kingdom) a development-stage medical device company focused on DNA sequencing via an electronic, label-free analysis of single molecule platform, closed a $28M Series D financing. Participants include Lansdowne Partners, IP Group, Invesco Perpetual and Redmile Group.
14
Apr
2011
11
Apr
2011
Posted in I - Series C, Q - 1Q11, R - INTERNATIONAL, X - Anticoagulant, X - Device (Diagnostic)
Microvisk Technologies (United Kingdom) a clinical-stage diagnostic company focused on prothrombin time assays designed to provide patients and clinicians with INR values used to aid in the correct dosage of anti-coagulation meds such as warfarin, closed a $9.5M Series C financing. Participants include Porton Capital, Oxford Technology Management, New Hill Management, Midven, Rainbow Seed Fund [...]
04
Apr
2011
29
Mar
2011
Posted in I - Series B, Q - 1Q11, R - NORTH EAST, X - Device (Diagnostic), XX - PA
BioNanomatrix (Philadelphia, PA) commercial-stage developer of a nanochannel array chip, single-molecule imaging and analysis platform, closed a $23.3M Series B financing. Participants include Domain Associates, Gund Investment Corp., Battelle Ventures, Innovation Valley Partners and KT Venture Group.
22
Mar
2011